白云山：关于子公司药物进入Ⅱ期临床试验的公告

Group 1 - The core point of the article is that Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its subsidiary, Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd., has registered the Phase II clinical trial information for its children's Xiao Chai Hu granules on the National Medical Products Administration's clinical trial registration and information public platform [2] Group 2 - The announcement was made on the evening of September 22 [2] - The registration of the clinical trial indicates progress in the development of the children's medication [2] - This development may enhance the company's product portfolio in the pediatric medicine sector [2]